Deferasirox methyl ester-d3
CAS: 1266741-05-2
Ref. 3D-RAC74105
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
Deferasirox methyl ester-d3
Description:
Deferasirox methyl ester-d3 is a cyclic ester compound. It is an iron chelator that has been shown to be effective in the process of removing excess iron from patients with thalassemia, a blood disorder. Deferasirox was developed by Novartis and is approved for use in Europe and the United States. This drug has no adverse effects on the body, but it can cause some side effects such as nausea, vomiting, diarrhea, and headache. These symptoms are usually mild and temporary.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
387.4 g/mol
Formula:
C22H17N3O4
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
